Itragreat SB 130 Capsule is a supra-bioavailable itraconazole capsule (130 mg) designed for enhanced absorption and consistent antifungal efficacy. Formulated to deliver reliable therapeutic levels, it is commonly prescribed for moderate to severe fungal infections involving the skin, nails, lungs, and systemic tissues. This advanced itraconazole formulation helps inhibit fungal cell membrane synthesis, ensuring faster and more dependable results compared to conventional options. Widely trusted by dermatologists and physicians, Itragreat SB 130 supports effective management of chronic dermatophytosis, candidiasis, and other resistant fungal infections when used under medical guidance.